MBX vs. OMER
MBX (MBX Biosciences, Inc) and OMER (Omeros Corporation) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past year, MBX returned 379.49% vs 227.98% for OMER. Their 0.28 correlation means their historical movements had little consistent relationship.
Performance
MBX vs. OMER - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MBX achieves a 109.04% return, which is significantly higher than OMER's -31.06% return.
MBX
- 1D
- -0.80%
- 1M
- 14.07%
- 6M
- 78.91%
- YTD
- 109.04%
- 1Y
- 379.49%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 75.19%
OMER
- 1D
- -0.75%
- 1M
- 27.59%
- 6M
- 1.28%
- YTD
- -31.06%
- 1Y
- 227.98%
- 3Y*
- 41.60%
- 5Y*
- -3.97%
- 10Y*
- -0.03%
- ALL TIME*
- 1.78%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $35.29M | $45.81M | $39.35M | |
| $16.98M | $15.21M | $19.60M |
MBX vs. OMER - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
MBX MBX Biosciences, Inc | 109.04% | 71.13% | -19.87% |
OMER Omeros Corporation | -31.06% | 73.84% | 164.17% |
Correlation
The correlation between MBX and OMER is 0.25, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.25 |
Correlation (All Time) Calculated using the full available price history since Sep 13, 2024 | 0.28 |
Fundamentals
MBX:
$3.14B
OMER:
$856.92M
MBX:
-$2.22
OMER:
-$0.05
MBX:
$0.00
OMER:
$0.00
MBX:
-$160.00K
OMER:
-$10.29M
MBX:
-$96.31M
OMER:
-$110.44M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MBX vs. OMER — Risk / Return Rank
MBX
OMER
MBX vs. OMER - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for MBX Biosciences, Inc (MBX) and Omeros Corporation (OMER). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MBX | OMER | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.92 | ||
| Sortino ratioReturn per unit of downside risk | +0.11 | ||
| Omega ratioGain probability vs. loss probability | 1.50 | 1.52 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 10.66 | 4.19 | +6.47 |
| Martin ratioReturn relative to average drawdown | 20.82 | 7.55 | +13.28 |
Loading charts...
Drawdowns
MBX vs. OMER - Drawdown Comparison
The maximum MBX drawdown since its inception was -77.71%, smaller than the maximum OMER drawdown of -95.95%. Use the drawdown chart below to compare losses from any high point for MBX and OMER.
Loading charts...
Drawdown Indicators
| MBX | OMER | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -77.71% | -95.95% | +18.24% |
Max Drawdown (1Y)Largest decline over 1 year | -37.60% | -49.52% | +11.92% |
Max Drawdown (3Y)Largest decline over 3 years | — | -75.56% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -93.37% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -95.95% | — |
Current DrawdownCurrent decline from peak | -0.80% | -55.64% | +54.84% |
Average DrawdownAverage peak-to-trough decline | -32.68% | -48.60% | +15.92% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 19.21% | 27.43% | -8.22% |
Volatility
MBX vs. OMER - Volatility Comparison
The current volatility for MBX Biosciences, Inc (MBX) is 22.35%, while Omeros Corporation (OMER) has a volatility of 24.61%. This indicates that MBX experiences smaller price fluctuations and is considered to be less risky than OMER based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MBX | OMER | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.35% | 24.61% | -2.26% |
Volatility (6M)Calculated over the trailing 6-month period | 54.44% | 52.47% | +1.97% |
Volatility (1Y)Calculated over the trailing 1-year period | 133.51% | 188.53% | -55.02% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 116.49% | 135.68% | -19.19% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 116.49% | 111.33% | +5.16% |
Dividends
MBX vs. OMER - Dividend Comparison
Neither MBX nor OMER has paid dividends to shareholders.
Financials
MBX vs. OMER - Financials Comparison
This section allows you to compare key financial metrics between MBX Biosciences, Inc and Omeros Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MBX and OMER have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
OMER has higher volatility (24.61%) compared to MBX (22.35%). In terms of maximum drawdown, MBX dropped -77.71% vs OMER's -95.95%.
MBX currently has the higher Sharpe Ratio (3.02 vs 1.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MBX and OMER
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer